Humanicsxians of the World Unite For a Better World For All Humanity Across Mother Earth

Humanics The Sociology of Evil: The Architectonics of Rationality

Humanics The Foundation: The Case for The Universal Assembly of the Humanion

|| Hope Is the Seed Sign and Science of Progress ||
 

 

 

 

 

 

 

 

 

 

 

 
|| The Humanion: Year Eta The Seventh Year: London: Monday: June 06: 2022 || Humanics: To End the Savagery Called Capitalism

The Humanion Web Map: For All Our Coverage

Contact Epigenomics Editorial   Medicine Humanics Neurology The World Life Elle The Humanion Portable Daily The Humanion Larnaarch
Society Jurisprudence Humanicsxian Economics Political Philosophy Genetics Ecology Advertise in The Humanion Regine Group of Publications
Sanctum Mayakardium Australasia Asia Africa N America S America Europe Culture The Humanion Team Regine Humanics Foundation
The Distorteddia Humanical Moral Science Humanical Sociology Geo-Politics England The Idearian Join Our Team Humanical Psychology
Humanics Spring Festival 2023: April 06 Humanical Jurisprudence United Kingdom Regine Humanics Lecture 2023: April 06 London Poetry Festival 2022: October 14-15
|| Support The Foundation ||
First Published: September 24: 2015
Regine Humanics Foundation Ltd
The Humanion UK Online Daily

 

As the Mother Earth Belongs to Every Single Human Being of the Humanion Regine Humanics Foundation Ltd and The Humanion Belong to All for We are a Human Enterprise: A Not for Profit Social Enterprise: Support Your Daily Quality Newspaper and Let Us Build an Institution That Will Flow with Time with the Rainbow Peoples of This Earth Far Into the Flowing Future: Support The Humanion: Support Regine Humanics Foundation Ltd

 

 

 

 

 

Biomedicojurisprudence
 Nuffield Council of Bioethics Responds to the Announcement of UK COVID-19 Human Challenge Trials

 

|| Wednesday: November 11: 2020 || ά. On October 20 the UK Government announced that it would work with partners to develop a COVID-19 human challenge study model. This will include the manufacture of the challenge virus and will be the first in-human characterisation study for COVID-19. In human challenge studies, participants are deliberately infected with the virus in question in order to gain knowledge in controlled circumstances about how the virus behaves or, in order to see, if, an investigational vaccine provides protection.

In response to this Nuffield Council of Bioethics has said the following: Given the scale of the global challenges, that COVID-19 poses, challenge trials could, potentially, play a useful role alongside the many other studies, currently taking place. However, they come with their own unique set of ethical considerations and risks, that must be addressed by all those, involved in the study, a properly constituted ethics committee, researchers and funders.

The World Health Organisation:WHO has published guidance on the issues, that such a committee should consider and, also, recommended that any proposed COVID challenge study should be reviewed by a specialist ethics committee with the necessary scientific and ethical expertise. We understand that the Health Research Authority has established such a specialist ethics committee in order to be prepared for any applications to run a challenge trial in the UK and we warmly welcome the establishment of this committee.

Today’s announcement highlights an early stage of the human challenge trial process and will require ethical approval before it goes ahead. Those, involved in the developing the study model and in any specific research proposal, must, now, consider the following:

::: Scientific justification: is a challenge study the most appropriate approach? Can the same benefit be gained for lower risk in a different kind of study?

::: Engagement with the wider public. Researchers and funders must consult and engage with the wider public from the beginning. They must make sure that public concerns are properly understood and addressed and that anxieties based on misconceptions can be avoided.

::: Assessment of risks and benefits: potential benefits must outweigh risks, taking into account the interests of three groups: participants, society in general and third-party contacts of participants. Researchers and funders must consider what actions must be taken to minimise risks, such as, finding an appropriate dose of the challenge virus and mitigate those risks, that remain, for example, by determining which volunteers are highly unlikely to develop serious disease, how volunteers will be monitored and ensuring that they have access to the best possible care.

::: Informed consent: There are significant challenges in ensuring volunteers thoroughly understand the risks and the uncertainty of any benefit. Volunteers will, also, be committing to stay within a bio-secure facility until they are no longer infectious.

The Council hopes that this process will involve a wide range of voices in considering how this might go forward.

|| Free Annual Subscription to The Humanion Portable Daily For Students: Workers: Unwaged: Journalism and Media Workers ||

|| Readmore  || :::ω:::  ||  reginehumanicsfoundation.com  ||  121120 || Up ||

 

 

 

 

The World Health Organisation Establishes Expert Panel to Develop World Standards for Governance and Oversight of Human Gene Editing

 

 

|| December 17: 2018 || ά. The World Health Organisation:WHO is establishing a global multi-disciplinary expert panel to examine the scientific, ethical, social and legal challenges, associated with human gene editing, both somatic and germ cell. The panel will review the current literature on the state of the research and its applications and societal attitudes towards the different uses of this technology.

WHO will, then, receive advice from the panel on appropriate oversight and governance mechanisms, both at the national and international level. Core to this work will be understanding how to promote transparency and trustworthy practices and how to ensure appropriate risk:benefit assessments are performed prior to any decision on authorisation.

The recent application of tools, such as, CRISPR-Casp9 to edit the human genome, have highlighted the need for the development of standards in this area. WHO’s expert working group will work in a consultative manner and build on existing initiatives.

As WHO proceeds, it is liaising with relevant UN and other international agencies and is in communication with the Academies of Science and Medicine, as well as, with bodies, that have produced previous reports.

WHO will be approaching leading experts in the world and publishing the membership of the panel, once, it receives responses and assesses conflicts of interest.:::ω. 

|| Readmore || 181218 || Up || 

 

Life's Laurel Is You In One-Line-Poetry A Heaven-Bound Propagated Ray Of Light Off The Eye Of The Book Of Life: Love For You Are Only Once

 

 

Life: You Are The Law The Flow The Glow: In Joys In Hurts You Are The Vine-Songs On The Light-Trellis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Subscribe to The Humanion Portable Daily For Just £100 a Year

Newspapers Press and Media Are Either Progressive or Regressive in the Sphere of Public Discourse: Readers Choose Which to Support
The Humanion Portable Daily Belongs to the Progressive Path: Read and Support Building the Voice of the Dispossessed for Change

 

 

 

 

 

                                                  

                                                      Read The Humanion Portable Daily

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

|| All copyrights @ The Humanion: London: England: United Kingdom || Contact: The Humanion: editor at thehumanion.com || Regine Humanics Foundation Ltd: reginehumanics at reginehumanicsfoundation.com || Editor-In-Chief: Munayem Mayenin || First Published: September 24: 2015 ||
|| Regine Humanics Foundation Ltd: A Human Enterprise: Registered as a Not For Profit Social Enterprise in England and Wales: Company No: 11346648 ||